{"id":"NCT02040090","sponsor":"Kamada, Ltd.","briefTitle":"Phase II/III Study of the Safety and Effectiveness of HRIG With Active Rabies Vaccine in Healthy Subjects","officialTitle":"A Prospective, Randomized, Double-Blind, Non Inferiority, Phase II/III Study of the Safety and Efficacy of Simulated Post-Exposure Prophylaxis With Kamada Human Rabies Immune Globulin (KamRAB) and Active Rabies Vaccine in Healthy Subjects","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2013-04","primaryCompletion":"2014-08","completion":"2014-08","firstPosted":"2014-01-20","resultsPosted":"2021-09-29","lastUpdate":"2021-09-29"},"enrollment":118,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"HEALTH_SERVICES_RESEARCH"},"conditions":["Rabies"],"interventions":[{"type":"DRUG","name":"Active rabies vaccine (US-FDA approved)","otherNames":["RabAvert®"]}],"arms":[{"label":"KamRAB","type":"EXPERIMENTAL"},{"label":"FDA approved HRIG product","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to: 1. Evaluate the safety and tolerability of KamRAB in comparison with Human rabies immune globulin (HRIG) comparator product. 2. To assess whether KamRAB interferes with the development of self active antibodies when given simultaneously with active rabies vaccine, as compared to the HRIG comparator product, also given in conjunction with the active rabies vaccine.","primaryOutcome":{"measure":"The Difference Between KamRAB and HRIG Comparator, in the Proportions of Subjects With Serum Anti-rabies IgG Antibody Concentration ≥ 0.5 IU/mL","timeFrame":"Day 14","effectByArm":[{"arm":"KamRAB","deltaMin":55,"sd":null},{"arm":"HRIG Comparator Product","deltaMin":58,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":9,"exclusionCount":26},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":59},"commonTop":["Injection site pain","Headache","Upper respiratory tract infection","Myalgia","Nausea"]}}